Notice Number: NOT-HG-18-013
Key Dates
Release Date: August 23, 2018
PAR-18-714
Issued by
National Human Genome Research Institute ( NHGRI )
National Institute of Allergy and Infectious Diseases (NIAID)
National Library of Medicine (NLM)
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to inform potential applicants that the National Human Genome Research Institute (NHGRI), the National Institute of Allergy and Infectious Diseases (NIAID), the National Library of Medicine (NLM), and the National Cancer Institute (NCI) will participate, effective immediately, in PAR-18-714 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed).
The following changes have been made in PAR-18-714 to reflect the participation of these NIH entities in this funding opportunity announcement (FOA):
Part 1. Overview Information
Text has been added to PAR-18-714 under each of the headings (below) as follows:
Components of Participating Organizations
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Library of Medicine (NLM)
National Cancer Institute (NCI)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.172; 93.855; 93.879; 93.393; 93.394; 93.395; 93.396; 93.399
Part 2. Section I. Funding Opportunity Description
National Human Genome Research Institute (NHGRI)
NHGRI will accept applications that support the development of resources, approaches, and technologies that will accelerate genomic research on the structure of genomes, the biology of genomes, and the biology of disease; that will advance the science of genomic medicine; and that will incorporate genomics to improve the effectiveness of healthcare. NHGRI will also support research in several cross-cutting areas, including the ethical, legal and societal implications of genomics and genetics research, bioinformatics, technology development, and research training and career development.
In general, NHGRI supports studies that provide generalizable genomics methods and knowledge. Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. NHGRI strongly encourages potential applicants to contact program staff in the early stages of developing an application.
National Institute of Allergy and Infectious Diseases (NIAID)
NIAID supports basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases, with the goal of developing new therapies, vaccines, diagnostic tests, and other technologies. Research areas include microbiology and infectious diseases, AIDS and AIDS -related research, immunology, allergy, transplantation, and biodefense.
https://www.niaid.nih.gov/research/role.
National Library of Medicine (NLM)
The National Library of Medicine (NLM) supports innovative research and development in biomedical informatics and data science. The scope of NLM's interest in these research domains is broad, with emphasis on new methods and approaches to foster data driven discovery in the biomedical and clinical health sciences as well as domain-independent, reusable approaches to discovery, curation, analysis, organization and management of health-related digital objects. Biomedical informatics and data science draw upon many fields, including mathematics, statistics, information science, computer science and engineering, and social/behavioral sciences. Application domains include health care delivery, basic biomedical research, clinical and translational research, precision medicine, public health, biosurveillance, health information management in disasters, and similar areas. NLM defines biomedical informatics as the science of optimal representation, organization, management, integration and presentation of information relevant to human health and biology. NIH defines data science as the interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are developed and used to extract knowledge and insights from increasingly large and/or complex sets of data.
National Cancer Institute (NCI)
The NCI is the Federal Government's principal agency for cancer research and control. Programs of the NCI focus on: (1) cancer etiology including laboratory, field, and epidemiologic and biometric research on the cause and natural history of cancer and means for preventing cancer, as well as studies on the mechanisms of cancer induction and promotion by chemicals, viruses, and environmental agents; (2) cancer biology and diagnosis research in the areas of cell biology, immunology, molecular biology, developmental biology, biochemistry, genetics, and pathology; (3) cancer metastasis research in the areas of invasion, cell migration, progression, and metastasis, and the studies focusing on tumor-host interactions; (4) cancer treatment research in the areas of drug development and biological response in controlling cancer; (5) early detection and diagnosis research, including studies of promising biomarkers; and (6) cancer prevention and control research, development, technology transfer, demonstration, and education and information dissemination programs to expedite the use of new information relevant to prevention, detection, and diagnosis of cancer and pretreatment evaluation, treatment, rehabilitation, and continuing care of cancer patients.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Bettie J. Graham, Ph.D.
National Human Genome Research Institute (NHGRI)
Phone: 301-496 7531
Email: Bettie_graham@nih.gov
NIAID AI Training Help Desk
AITrainingHelpDesk@niaid.nih.gov
Hua-Chuan Sim, M.D.
National Library of Medicine (NLM)
Telephone: 301-594-4882
Email: simh@mail.nih.gov
Christopher L. Hatch, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6454
Email: ch29v@nih.gov
Financial/Grants Management Contact(s)
Deanna L. IngersollNational Human Genome Research Institute (NHGRI)
Phone: 301-435-7858
Email: Deanna.Ingersoll@nih.gov
David Madoo
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-761-6446
Email: david.madoo@nih.gov
Samantha Tempchin
National Library of Medicine (NLM)
Telephone: 301-496-4221
Email: tempchins@mail.nih.gov
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@mail.nih.gov
All other aspects of this FOA remain unchanged
Inquiries
Please direct all inquiries to:
Bettie J. Graham, Ph.D.
National Human Genome Research Institute (NHGRI)
Phone: 301-496 7531
Email: Bettie_graham@nih.gov
NIAID AI Training Help Desk
AITrainingHelpDesk@niaid.nih.gov
Hua-Chuan Sim, M.D.
National Library of Medicine (NLM)
Telephone: 301-594-4882
Email: simh@mail.nih.gov
Christopher L. Hatch, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6454
Email: ch29v@nih.gov
and Human Services (HHS)
